Cleared Abbreviated

StentBoost Mobile (K203623) - FDA 510(k) Clearance

Class II Radiology device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

K203623 · Philips India Limited · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2021
Decision
115d
Days
Class 2
Risk

K203623 is an FDA 510(k) clearance for the StentBoost Mobile. Classified as Interventional Fluoroscopic X-ray System (product code OWB), Class II - Special Controls.

Submitted by Philips India Limited (Pune, IN). The FDA issued a Cleared decision on April 5, 2021 after a review of 115 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1650 - the FDA radiology and imaging software oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Philips India Limited devices

Submission Details

510(k) Number K203623 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 11, 2020
Decision Date April 05, 2021
Days to Decision 115 days
Submission Type Abbreviated
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d slower than avg
Panel avg: 107d · This submission: 115d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code OWB Interventional Fluoroscopic X-ray System
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1650
Definition Interventional Fluoroscopy
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - OWB Interventional Fluoroscopic X-ray System

All 190
Devices cleared under the same product code (OWB) and FDA review panel - the closest regulatory comparables to K203623.
Virtual C DRF Digital Imaging System
K211191 · Portavision Medical, LLC · Jun 2021
Trinias
K203535 · Shimadzu Corporation Medical Systems · Apr 2021
Alphenix, INFX-8000C/B, INFX-8000C/S, V9.2
K210900 · Canon Medical Systems Corporation · Apr 2021
Surgivisio system
K202547 · Surgivisio · Mar 2021
Cios Select (VA21) Flat Panel
K210309 · Siemens Medical Solutions USA, Inc. · Mar 2021
Cios Select (VA21) Image Intensifier
K210307 · Siemens Medical Solutions USA, Inc. · Mar 2021